Response to "Intraurethral Lidocaine Use During Urodynamic Testing Deserves Further Study"

Comment

Cassandra K Kisby et al. Female Pelvic Med Reconstr Surg. 2020 Jul.

. 2020 Jul;26(7):465.

doi: 10.1097/SPV.0000000000000793.

No abstract available

Comment on

Randomized Controlled Trial to Assess the Impact of Intraurethral Lidocaine on Urodynamic Voiding Parameters.
Kisby CK, Gonzalez EJ, Visco AG, Amundsen CL, Grill WM. Kisby CK, et al. Female Pelvic Med Reconstr Surg. 2019 Jul/Aug;25(4):265-270. doi: 10.1097/SPV.0000000000000544. Female Pelvic Med Reconstr Surg. 2019. PMID: 29300256 Free PMC article. Clinical Trial.
Intraurethral Lidocaine Use During Urodynamic Testing Deserves Further Study.
Hegan C, Rahn DD. Hegan C, et al. Female Pelvic Med Reconstr Surg. 2020 Jul;26(7):464. doi: 10.1097/SPV.0000000000000789. Female Pelvic Med Reconstr Surg. 2020. PMID: 32609462 No abstract available.